News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
268
Sources here
23
Companies here
10
Search results Stored financial headlines

Active search

268 matching headlines

Ticker or company: DIVMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Diversified Healthcare Trust (Nasdaq: DHC) reports Q2 2026 FFO up 109%

Diversified Healthcare Trust (DHC) reported strong Q2 2026 financial results, with Normalized FFO increasing by 109.4% year-over-year to $38.9 million. The company saw significant improvements in its senior housing operating portfolio, with same property SHOP NOI growing 37.2%, and its Medical Office and Life …

DHC main company
Sharemaestro market context Trend signal active 52 weeks +121.8% DHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Join Class Action to Recover Losses From Compass Group Diversified Holdings, LLC (CODI) - Contact Levi & Korsinsky Before July 8, 2025

Levi & Korsinsky LLP has filed a class action securities lawsuit against Compass Group Diversified Holdings, LLC (CODI) for alleged securities fraud between February 24, 2022, and May 7, 2025. The lawsuit claims Compass failed to disclose critical information about its subsidiary Lugano Holding, …

CODI main company
Sharemaestro market context Trend signal active 52 weeks +66.1% CODI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Supernus, Indivior merge to beef up brain drug portfolio

Brain drug developers Supernus and Indivior have announced a merger aimed at combining their portfolios of neurological drugs. The new entity, to be called Supernus, will have a combined revenue of $2 billion (2025 figures) and aims to achieve annual cost reductions of $125 …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diversified Healthcare earnings on deck after guidance raise

Diversified Healthcare Trust is set to report its Q2 results, with analysts expecting a loss of $0.14 per share on $367.6 million in revenue, an improvement from the previous quarter. Investors will be looking to see if the company can deliver on its raised …

DHC main company
Sharemaestro market context Trend signal active 52 weeks +121.8% DHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior Shares Surge After Strong Quarterly Results and Higher 2026 Outlook

Stock chart with red arrow going up ©Pixabay Indivior Pharmaceuticals Inc. (NASDAQ:INDV) reported better-than-expected second-quarter 2026 results on Monday, driven by record sales of its opioid use disorder treatment SUBLOCADE, while raising its full-year financial guidance. The stronger outlook sent the pharmaceutical company's shares …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior stock soars 9% on strong earnings beat and raised guidance

Indivior Pharmaceuticals Inc. (NASDAQ:INDV) saw its stock rise by 9.22% after reporting strong second-quarter results that exceeded analyst expectations. The company also raised its full-year 2026 revenue and adjusted EBITDA guidance, driven by record SUBLOCADE net revenue. This performance reflects strong operational execution and …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(WDI) Movement as an Input in Quant Signal Sets

The article analyzes Western Asset Diversified Income Fund Of Beneficial Interest (NYSE: WDI) using AI models, identifying a neutral near-term sentiment and a mid-channel oscillation pattern. It presents three institutional trading strategies tailored to different risk profiles, including long, breakout, and short positions, along …

WDI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 65.8% WDI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Supernus and Indivior Combine to Build $2.2B CNS Biopharmaceutical Company

Supernus Pharmaceuticals and Indivior Pharmaceuticals are merging in an all-stock deal to form a $2.2 billion central nervous system (CNS) biopharmaceutical company. The combined entity, operating as Supernus, Inc., will integrate Indivior's opioid use disorder franchise, centered on SUBLOCADE, with Supernus's diverse neurology and …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Indivior Pharmaceuticals reported strong second-quarter 2026 financial results, with total net revenue up 14% year-over-year to $343 million and SUBLOCADE net revenue increasing by 21% to $253 million. The company has raised its full-year 2026 guidance, now expecting total SUBLOCADE net revenue growth of …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 4 Indivior PLC For: 3 August By Investing.com

This article announces the filing of Form 4 for Indivior PLC on August 3rd. It appears to be a very brief notification from Investing.com, typical of automated financial news updates regarding regulatory filings. The content primarily consists of navigation, advertisements, and market data rather …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Moderate Buy" by Brokerages

Indivior PLC (NASDAQ:INDV) has received an average "Moderate Buy" recommendation from seven brokerages, with an average 12-month price target of $43.67. The company's stock opened at $40.01, and analysts project full-year earnings of $4.05 per share. Recent insider transactions show executives selling shares under …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior Q2 2026 slides: SUBLOCADE drives 111% EBITDA surge

Indivior PLC reported strong Q2 2026 financial results, with adjusted EBITDA surging 111% driven by its opioid use disorder treatment, SUBLOCADE. Despite exceeding analyst expectations, the company's stock experienced a slight decline, likely due to investor caution regarding its proposed merger with Supernus Pharmaceuticals. …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior Q2 Earnings Call Highlights

Indivior and Supernus Pharmaceuticals announced an all-stock merger of equals, expected to close in Q4 2026, creating a CNS-focused biopharmaceutical company with approximately $2.2 billion in pro forma trailing-12-month net revenue. The combined entity will retain the Supernus name and be led by Supernus …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior PLC Lobbyists, 2023

This article from OpenSecrets details Indivior PLC's lobbying activities and lobbyists for the year 2023. It identifies 19 named lobbyists, with 15 (78.9%) having a "revolving door" background, meaning prior federal government employment. The report breaks down lobbyists by hiring firm, including Williams & …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medalist Diversified REIT Closes Kansas Automotive Property Acquisition

Medalist Diversified REIT (MDRR) has finalized the acquisition of a 1.64-acre property with a 16,100-square-foot automotive service building in Overland Park, Kansas, for $5.8 million, funded by cash on hand. The acquisition was structured through a Delaware statutory trust, allowing the REIT to offer …

MDRR main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% MDRR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior PLC (INDV) Financial Health: Profitability & Balance Sheet Analysis

Indivior PLC (INDV) has a current financial score of 7.94, ranking 87th out of 155 in the Pharmaceuticals industry, indicating a weak financial status despite high operating efficiency. The company reported a 19.17% year-over-year increase in quarterly revenue to $317.00 million and a 93.48% …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ex-Div Reminder for Modiv Industrial (MDV)

Looking at the universe of stocks we cover at Dividend Channel, on 7/31/26, Modiv Industrial Inc (Symbol: MDV) will trade ex-dividend, for its monthly dividend of $0.10, payable on 8/10/26. As a percentage of MDV's recent stock price of $17.71, this dividend works out …

MDV main company
Sharemaestro market context Trend signal active 52 weeks +25.4% MDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior Number of Employees 2026 | Employee Count & Headcount Data

Indivior Ltd. has an estimated 1,015 employees worldwide as of March 2026, marking a 25.4% decline in headcount since 2023. The Pharmaceuticals company, headquartered in Bon Air, Virginia, is actively hiring with 50 job postings in 2026, though this represents a 5.8% decline from …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RBF Capital LLC Decreases Stake in Diversified Healthcare Trust $DHC

RBF Capital LLC reduced its stake in Diversified Healthcare Trust (DHC) by 15.5% in the first quarter, selling 177,475 shares and retaining 966,829 shares valued at $6.42 million. Diversified Healthcare Trust's stock has an average rating of "Moderate Buy" from analysts, with an average …

DHC main company
Sharemaestro market context Trend signal active 52 weeks +121.8% DHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(DHCNL) Movement as an Input in Quant Signal Sets

This article analyzes Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (NASDAQ: DHCNL), highlighting a weak near-term sentiment despite potential long-term strength. It presents AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes multi-timeframe signal …

DHC main company
Sharemaestro market context Trend signal active 52 weeks +121.8% DHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Indivior PLC (INDV) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Indivior PLC (INDV), highlighting its strong valuation score of 9.73, which ranks it highly within the Pharmaceuticals industry. It details the company's current P/E ratio, its market capitalization, and stock performance, while noting that data for P/B, …

INDV main company
Sharemaestro market context Trend signal active 52 weeks +60.4% INDV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context